Sources: CBC
The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers. 2021-05-8
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
The government signs a deal with Pfizer and BioNTech to buy an additional 12.2 million doses of the tozinameran vaccine. 2021-01-11
Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy. 2021-01-4
Ireland officially begins a vaccination programme against COVID-19 using Pfizer-BioNTech's tozinameran vaccine, with a 79-year-old woman from Dublin becoming the first person to receive the vaccine. 2020-12-29
Qatar begins administering the Pfizer-BioNTech vaccine tozinameran to its citizens at designated health centers in the country. Those aged over 70, adults with chronic health conditions and healthcare personnel are to be prioritised for the vaccine. 2020-12-23
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
Pfizer and BioNTech announce that they will ask the European Medicines Agency to approve their potential vaccine candidate. 2020-12-1
Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases. 2020-11-20